Bristol Myers Lung Cancer Drug Krazati Succeeds in Late-stage Trial
Immunocore Touts Updated Phase 1 Results for Melanoma Asset Brenetafusp
Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady in April: This Week in the Market
The U.S. stock market ended a five-week positive streak as investors feared that slowing economic momentum could impact the earnings outlook for American corporations.
Check Out What Whales Are Doing With IBM
Investors with a lot of money to spend have taken a bearish stance on IBM (NYSE:IBM).And retail traders should know.We noticed this today when the trades showed up on publicly available options histor
FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies
On Thursday, the FDA approved Bristol Myers Squibb Co's (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refrac
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Novartis Boasts Scemblix Beats Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Strike At Exxon Site On Hold: Talks Heat Up Over Severance Packages
A strike at Exxon Mobil Corporation's (NYSE:XOM) petrochemical complex in northern France is reportedly expected to remain suspended through June 4 as talks are held over severance packages.The strike
Hess Shareholders Narrowly Approved Sale to Chevron With 51% Vote
Chevron's Gorgon LNG Resumes Full Production After Outage
AbbVie Wins EU Backing for Skyrizi in Bowel Disorder
10 Financials Stocks Whale Activity In Today's Session
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth.
Bristol-Myers Squibb's Options: A Look at What the Big Money Is Thinking
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga
Exxon Shrinks Footprint In Nigeria Despite Renewal Of Lease On Lagos Office: Report
Exxon Mobil Corporation (NYSE:XOM) is renewing a 33-year-old lease on its expansive offices in Lagos's upscale Lekki district.The lease was set to expire on Friday.The move comes after it plans to sca
Industrial Stocks With a Favorable GARP Strategy - BMO Capital Markets
Wall Street's Most Accurate Analysts' Views On 3 Tech Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
AbbVie Shares Fell for Seven Straight Days
Smart Money Is Betting Big In UPS Options
Deep-pocketed investors have adopted a bearish approach towards United Parcel Service (NYSE:UPS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga
Check Out What Whales Are Doing With Morgan Stanley
Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley (NYSE:MS).
IBM Options Trading: A Deep Dive Into Market Sentiment
Financial giants have made a conspicuous bullish move on IBM. Our analysis of options history for IBM (NYSE:IBM) revealed 10 unusual trades.Delving into the details, we found 60% of traders were bulli